Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
46.60
-0.91 (-1.92%)
At close: Sep 4, 2026, 4:00 PM EDT
46.55
-0.05 (-0.11%)
After-hours: Sep 4, 2026, 7:59 PM EDT
Novo Nordisk Employees
Novo Nordisk had 69,505 employees as of December 31, 2025. The number of employees decreased by 7,844 or -10.14% compared to the previous year.
Employees
69,505
Change (1Y)
-7,844
Growth (1Y)
-10.14%
Revenue / Employee
$724,276
Profits / Employee
$256,008
Market Cap
205.51B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 69,505 | -7,844 | -10.14% |
| Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
| Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
| Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
| Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
| Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
| Dec 31, 2019 | 43,258 | 56 | 0.13% |
| Dec 31, 2018 | 43,202 | 520 | 1.22% |
| Dec 31, 2017 | 42,682 | 711 | 1.69% |
| Dec 31, 2016 | 41,971 | 1,333 | 3.28% |
| Dec 31, 2015 | 40,638 | -319 | -0.78% |
| Dec 31, 2014 | 40,957 | 2,521 | 6.56% |
| Dec 31, 2013 | 38,436 | 3,705 | 10.67% |
| Dec 31, 2012 | 34,731 | 2,099 | 6.43% |
| Dec 31, 2011 | 32,632 | 2,149 | 7.05% |
| Dec 31, 2010 | 30,483 | 1,154 | 3.93% |
| Dec 31, 2009 | 29,329 | 2,754 | 10.36% |
| Dec 31, 2008 | 26,575 | 1,059 | 4.15% |
| Dec 31, 2007 | 25,516 | 1,903 | 8.06% |
| Dec 31, 2006 | 23,613 | 1,153 | 5.13% |
| Dec 31, 2005 | 22,460 | 1,735 | 8.37% |
| Dec 31, 2004 | 20,725 | 1,969 | 10.50% |
| Dec 31, 2003 | 18,756 | 751 | 4.17% |
| Dec 31, 2002 | 18,005 | 1,864 | 11.55% |
| Dec 31, 2001 | 16,141 | 2,389 | 17.37% |
| Dec 31, 2000 | 13,752 | 1,758 | 14.66% |
| Dec 31, 1999 | 11,994 | 345 | 2.96% |
| Dec 31, 1998 | 11,649 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Pfizer | 75,000 |
| Merck & Co. | 75,000 |
| Sanofi | 74,846 |
| GSK plc | 66,841 |
| AbbVie | 57,000 |
NVO News
- 1 day ago - Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze. - Market Watch
- 2 days ago - 2 Stocks Down 8% or More That Are Screaming Buys Right Now - The Motley Fool
- 2 days ago - Novo Nordisk owner, Quantum Foundry establish chip fab facility in Copenhagen - TheFly
- 4 days ago - Novo Nordisk AS (NVO) Stock Up 3.7% and Still Undervalued -- GF Score: 76/100 - GuruFocus
- 4 days ago - Pharma Giant Novo Nordisk Stock (NVO) Jumps Even as Deutsche Bank Repeats Sell Call - TipRanks
- 5 days ago - Novo Nordisk Trades Nearly 58% Below GF Value as Wegovy Pill Launches in Germany - GuruFocus
- 5 days ago - Novo Nordisk launches Wegovy weight-loss pill in Germany - Reuters
- 6 days ago - GLP-1 weight loss drugs effective even at low starter doses - Reuters